World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00721721
Date of registration: 22/07/2008
Primary sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Public title: Analyzing Genetic Factors Involved in Blood Pressure Changes Due to Salt and Potassium Intake (The GenSalt Study) GenSalt
Scientific title: Genetic Epidemiology Network of Salt Sensitivity
Date of first enrolment: October 2003
Target sample size: 1906
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00721721
Study type:  Interventional
Study design:  Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic  
Countries of recruitment
China
Contacts
Name:   Jiang He, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Tulane University School of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

Inclusion Criteria for Primary Participants:

- Between 18 and 60 years old

- Systolic blood pressure level of 130 to 160 mm Hg and/or diastolic blood pressure
level of 85 to 100 mm Hg

- Both parents (2-generation nuclear family) or at least one parent (at least a
3-generation family) is available and willing to participate in the study

- At least one sibling meets eligibility criteria for participation

Inclusion Criteria for Sibling/Spouse/Child Participants:

- Siblings and spouses must be between 18 and 60 years old; children must be more than
16 years old

- Lives in the same village as the main study participant

Exclusion Criteria for All Participants:

- Current stage 2 hypertension (systolic blood pressure level greater than or equal to
160 mm Hg and/or diastolic blood pressure level greater than or equal to 100 mm Hg)

- Current or recent (i.e., less than 1 month before the screening visit) use of
antihypertensive medications or medications that affect blood pressure

- Secondary hypertension

- History of clinical cardiovascular disease, including heart attack, congestive heart
failure, stroke, and peripheral arterial disease

- Chronic kidney failure or urinary albumin concentration of greater than or equal to
20 mg/dL

- Current diabetes (i.e., fasting serum glucose level greater than or equal to 126
mg/dL) or use of insulin or oral hypoglycemic agents

- Peptic ulcer disease requiring treatment in the 2 years before study entry

- Liver disease requiring treatment in the 2 years before study entry

- Pregnant

- Heavy alcohol drinker (i.e., more than 14 drinks per week)

- Currently adhering to a low sodium diet



Age minimum: 18 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Blood Pressure
Intervention(s)
Behavioral: High Sodium Diet
Behavioral: Low Sodium Diet
Dietary Supplement: Potassium Supplementation
Primary Outcome(s)
Blood pressure [Time Frame: Measured at Day 21]
Secondary Outcome(s)
Secondary ID(s)
1412
U01 HL072507
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history